Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Clinical Studies Sponsored by Eli Lilly

Clinical Studies where

Trial Sponsor

Name	NCT Number	Health Conditions in Trial	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type
‌ A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas	NCT01445119		2007	2013	Interventional
‌ Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma	NCT00044863		2002	2005	Interventional
‌ Safety Study of Atomoxetine and Cerebrovascular Outcomes	NCT00634439	‌ Transient ischemic attack	2008	2008	Observational
‌ A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme	NCT00191828	Weight gain	2003	2005	Interventional
‌ Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes	NCT00192101	Metastatic breast cancer	2004	2005	Interventional
‌ Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy	NCT00083720	Neoplasm	2004	2008	Interventional
‌ A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer	NCT00192062	‌ Breast Cancer	2004	2007	Interventional
‌ A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease	NCT06297590		April 8, 2024	February 27, 2027	Interventional
‌ Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients	NCT00191802	Osteoporosis	2003	2005	Interventional
‌ A Study of LY2979165 and LY2140023 in Healthy Volunteers	NCT01524237		2012	2013	Interventional
‌ Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma	NCT00190801		2003	2005	Interventional
‌ Effect of LY2062430 on the Progression of Alzheimer's Disease	NCT00905372	Alzheimer's disease	2009	2012	Interventional
‌ Effect of LY2062430 on the Progression of Alzheimer's Disease	NCT00904683	Alzheimer's disease	2009	2012	Interventional
‌ Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease	NCT00244322	Alzheimer's disease	2005	2006	Interventional
‌ 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis	NCT00191425		2002	2005	Interventional
‌ A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)	NCT06280703	‌ Healthy	May 15, 2024	February 17, 2025	Interventional
‌ A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)	NCT06439277	Weight gain ‌ Obesity	2024	2027	Interventional
‌ The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)	NCT00279201		2005	2009	Interventional
‌ A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer	NCT00191347	‌ Breast Cancer	2004	2005	Interventional
‌ Teriparatide Use in Hip Replaced Subjects	NCT00191321	Osteoporosis	2004	2005	Interventional
‌ A Study of LY2979165 in Healthy Subjects	NCT01383967	Bipolar disorder	2011	2012	Interventional
‌ A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer	NCT00034268		2002		Interventional
‌ A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis	NCT00034476	Sepsis	2001	2002	Interventional
‌ A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer	NCT00190840		2003	2005	Interventional
‌ A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients	NCT01253278		2010	2011	Interventional

...

Results per page:

1,544 results

0 selected

1,544 results

0 selected